Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
UTE GRANA CAR-T is a Spanish temporary union of companies (Unión Temporal de Empresas) and research institutions focused on the development and production of academic CAR-T cell therapies. The consortium was established to advance the 'GRANA CAR-T' project, which aims to provide accessible, hospital-exempt chimeric antigen receptor T-cell treatments for hematological malignancies. The entity coordinates the manufacturing and clinical validation of CD19-targeted CAR-T therapies within the Spanish National Health System, specifically leveraging facilities in the Andalusia region. Its primary goal is to decentralize CAR-T production and reduce costs compared to commercial alternatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UTE GRANA CAR-T.